Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory study

The European LeukaemiaNet (ELN) measurable residual disease (MRD) working group has published consensus guidelines to standardize molecular genetic MRD testing of the t(8;21)(q22;q22.1) RUNX1::RUNX1T1, inv(16)(p13.1q22) CBFB::MYH11, t(15;17)(q24.1;q21.2) PML::RARA, and NPM1 type A markers. A study f...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Stuart, Dillon, Richard, Thiede, Christian, Sadiq, Sadia, Cartwright, Ashley, Clouston, Hazel J., Travis, Debbie, Mokretar, Katya, Potter, Nicola, Chantry, Andrew, Whitby, Liam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Myeloid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368676/
https://www.ncbi.nlm.nih.gov/pubmed/36939402
http://dx.doi.org/10.1182/bloodadvances.2022009379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368676/
https://www.ncbi.nlm.nih.gov/pubmed/36939402
http://dx.doi.org/10.1182/bloodadvances.2022009379

Ejemplares similares